Opportunity Overview
The disruption of slow wave sleep (SWS) is implicated in the pathogenesis and functional consequences of dementia. SWS is critical for clearing toxic dementia-linked proteins, and plays an essential role in memory consolidation. Amnestic Mild Cognitive Impairment (aMCI) is the earliest identifiable stage of dementia, with the majority of patients progressing to Alzheimer's disease. Sleep quality is altered in aMCI, and linked to subsequent waking cognitive performance, however, study samples have been small and lacking EEG measures of sleep. Consequently, the link between SWS, aMCI and disease progression is unknown. Identifying SWS changes in aMCI could provide a significant therapeutic target for both disease-modification and symptom management. Historically sleep has been measured using polysomnography, requiring participants to stay overnight in sleep clinics, wearing sleep disruptive equipment. This project will be the first of its kind to harness cutting edge mobile, wearable EEG technology to revolutionise the clinical assessment of sleep in the home environment, with no experimenter present. DreemTM are market leader and project partner.
The aims are to:
1. Characterise changes to sleep in aMCI using remote, home-based EEG data collection.
2. . Examine the relationship between SWS and waking cognitive performance
3. Develop mathematical models using sleep EEG and predict the conversion of MCI to dementia
Methods:
100 aMCI patients will be recruited from co-supervisor, Dr Coulthard's, ReMemBr Memory Clinic volunteer database of 1500 patients, over 2 years. They will complete standardised tests of cognition and sleep (ACE-III, PSQI), and be provided with a Dreem EEG headset and laptop. I will provide instructions to the patient and partner/carer via an online video call each night, for 1...
This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | MRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2022 |
| Procurement stage | Active solicitation |
| Response due | September 29, 2026 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.